Once-Weekly Semaglutide in Adolescents with Obesity. Reply

N Engl J Med. 2023 Mar 23;388(12):1146. doi: 10.1056/NEJMc2300510.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adolescent
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucagon-Like Peptides / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Pediatric Obesity*

Substances

  • semaglutide
  • Hypoglycemic Agents
  • Glucagon-Like Peptides